Brief: PCI Biotech Announces Discontinuation Of Research And Development Operations
08/01/2026 13:13
Jan 8 (Reuters) - PCI Biotech Holding ASA PCIB.OL: PCI BIOTECH ANNOUNCES DISCONTINUATION OF RESEARCH AND DEVELOPMENT OPERATIONS AND CONTINUES EVALUATION OF FUTURE OPTIONS LIQUIDITY POSITION OF PCI BIOTECH GROUP REMAINS CRITICAL THERE IS NO ASSURANCE THAT ADDITIONAL FINANCING CAN BE SECURED MATERIAL UNCERTAINTIES CAST SIGNIFICANT DOUBT ON PCI BIOTECH GROUP'S ABILITY TO CONTINUE AS A GOING CONCERN. Source text: ID:nGNE8Kqk9r Further company coverage: PCIB.OL (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process